Bristol Myers Squibb Announces Early Participation Results, Amendment and Early Settlement of Tender OffersBusiness Wire • 11/18/25
S&P 500 Gains and Losses Today: DoorDash Drives Higher on a New Partnership; Bristol-Myers Squibb Stock FallsInvestopedia • 11/14/25
Bristol Myers Faces Another Trial Disappointment As Heart Drug Milvexian Fails To Show EfficacyBenzinga • 11/14/25
Bristol Myers Slumps After Its Heart Condition Study Gets The BootInvestors Business Daily • 11/14/25
Sarah Cannon Research Institute and Bristol Myers Squibb Expand Strategic Collaboration to Accelerate Patient Enrollment and Broaden Access to Innovative Cancer ResearchBusiness Wire • 11/12/25
Bristol Myers Gains 7.2% in a Month: Buy, Sell or Hold the Stock?Zacks Investment Research • 11/10/25
Dispatch Bio Announces Clinical Supply and Collaboration Agreement with Bristol Myers Squibb in Solid TumorsBusiness Wire • 11/04/25
Bristol-Myers Squibb: Increased Global Breyanzi Sales Isn't Only Hematological Product GrowthSeeking Alpha • 11/03/25
Biotech is back. Here's why these rallying stocks belong in your portfolio now.Market Watch • 11/03/25
Bristol Myers Squibb Showcases New Long-Term and Real-World Data From Cardiovascular Portfolio at the American Heart Association Scientific Sessions 2025Business Wire • 11/03/25
Bristol Myers' New Treatments Drive Q3 Beat — And The Company's Raising Its OutlookBenzinga • 10/30/25